iPSC Quality Assessment and Karyotype Analysis
Contract Overview
Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.
AI Contract Overview
The contract involves performing comprehensive genomic stability testing, pluripotency validation, and karyotype confirmation on 94 induced pluripotent stem cell lines using G-banding or SNP array technologies to ensure their quality and genetic integrity. These analyses are critical for confirming that the cell lines maintain stable chromosomal structures and retain the essential characteristics of pluripotency required for downstream research or therapeutic applications. The work is being conducted under a subcontract issued by the National Institutes of Health through the Department of Health and Human Services, with the NAICS code 541620 indicating it falls under scientific research and development services. The proposal must be submitted by the deadline of July 31, 2026, and the performance location specifics are not provided, though the work is expected to meet rigorous technical standards aligned with federal research requirements.
General Info
Agency
NAICS
Place of Performance
MDSet-Aside
Documents
(0)AI Contract Breakdown
Uniform Contract FormatNo contract breakdown available.
Cannot generate Contract Breakdown because no documents were found from this contract's source.
Timeline
Response Deadline
Organization & Contact Information
Full Description
Similar Contracts
Same NAICS industry code
More opportunities from Department Of Health And Human Services → National Institutes Of Health Olao
Same awarding agency
